Highlights Societal CDMO, Inc.

Equities

SCTL

US75629F1093

Market Closed - Nyse Other stock markets 01:30:00 06/04/2024 am IST			5-day change	1st Jan Change
1.1 ^USD	+0.92%		-.--%	+213.84%

08/04	Societal CDMO, Inc. Announces Board and Committee Resignations	CI
08/04	Societal CDMO, Inc.(NasdaqCM:SCTL) dropped from NASDAQ Composite Index	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CoreRx, Inc. completed the acquisition of Societal CDMO, Inc. from First Light Asset Management, LLC and Others.	08/04	CI
Societal CDMO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/03	CI
CoreRx, Inc. entered into a definitive agreement to acquire Societal CDMO, Inc..	28/02	CI
Societal CDMO Signs Co-Marketing Deal With Benuvia Operations	01/02	MT
Societal CDMO, Inc and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers	01/02	CI
Earnings Flash (SCTL) SOCIETAL CDMO Posts Q3 Revenue $23.6M, vs. Street Est of $24.3M	09/11	MT
Societal CDMO, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
Societal CDMO, Inc. Resets Earnings Guidance for the Year 2023	09/11	CI
Societal Cdmo Secures Project Expansion Agreements with Several Existing Customers	07/23/07	CI
Earnings Flash (SCTL) SOCIETAL CDMO Reports Q2 Revenue $21.8M, vs. Street Est of $21.9M	15/23/15	MT
Societal CDMO, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Societal CDMO to Support Spinnaker Biosciences' Clinical Development of New Therapeutic Candidate	10/23/10	MT
Spinnaker Biosciences Selects Societal CDMO to Provide CDMO Services to Support Clinical Development of Novel Therapeutic Candidate	10/23/10	CI
Societal CDMO Agrees to Support CivicaScript's Generic Drug Candidate Development, Registration	29/23/29	MT
Societal CDMO Signs Master Service Agreement With CivicaScript to Provide CDMO Services	29/23/29	CI
Societal CDMO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI
Earnings Flash (SCTL) SOCIETAL CDMO Reports Q1 Revenue $21.5M, vs. Street Est of $20M	11/23/11	MT
Societal CDMO, Inc. Reaffirms 2023 Financial Guidance	11/23/11	CI
Xequel Bio, Inc. Selects Societal CDMO Services to Support Ongoing Clinical Development of iNexin	08/23/08	CI
Societal Cdmo, Inc. Signs Multiple Project Expansion Agreements with Existing Customers	12/23/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Societal CDMO, Inc.

Equities

SCTL

US75629F1093

Highlights

Filters